• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对包括奥密克戎在内的新型冠状病毒(SARS-CoV-2)变体的刺突蛋白多态性氨基酸进行注释。

Annotating Spike Protein Polymorphic Amino Acids of Variants of SARS-CoV-2, Including Omicron.

作者信息

Mahardika Gusti Ngurah, Mahendra Nyoman B, Mahardika Bayu K, Suardana Ida B K, Pharmawati Made

机构信息

The Animal Biomedical and Molecular Biology Laboratory, Udayana University, Jl. Sesetan-Markisa 6A, Denpasar 80223, Bali, Indonesia.

The Department of Obstetrics and Genecology, The Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.

出版信息

Biochem Res Int. 2022 Apr 11;2022:2164749. doi: 10.1155/2022/2164749. eCollection 2022.

DOI:10.1155/2022/2164749
PMID:35450296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9017565/
Abstract

The prolonged global spread and community transmission of severe acute respiratory syndrome virus 2 (SARS-CoV-2) has led to the emergence of variants and brought questions regarding disease severity and vaccine effectiveness. We conducted simple bioinformatics on the spike gene of a representative of each variant. The data show that a number of polymorphic amino acids are located mostly on the amino-terminal side of the S1/S2 cleavage site. The Omicron variant diverges from the others, with the highest number of amino acid substitutions, including the receptor-binding site (RBS), epitopes, S1/S2 cleavage site, fusion peptide, and heptad repeat 1. The current sharp global increase in the frequency of the Omicron genome constitutes evidence of its high community transmissibility. In conclusion, the proposed guideline could give an immediate insight of the probable biological nature of any variant of SARS-Cov-2. As the Omicron diverged the farthest from the original pandemic strain, Wuhan-Hu-1, we expect different epidemiological and clinical patterns of Omicron cases. On vaccine efficacy, slight changes in some epitopes while others are conserved should not lead to a significant reduction in the effectiveness of an approved vaccine.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在全球的长期传播和社区传播导致了病毒变体的出现,并引发了关于疾病严重程度和疫苗有效性的问题。我们对每个变体的代表性毒株的刺突基因进行了简单的生物信息学分析。数据显示,许多多态性氨基酸大多位于S1/S2裂解位点的氨基末端一侧。奥密克戎变体与其他变体不同,其氨基酸取代数量最多,包括受体结合位点(RBS)、表位、S1/S2裂解位点、融合肽和七肽重复序列1。目前奥密克戎基因组在全球的频率急剧上升,证明了其高社区传播性。总之,所提出的指导方针可以立即洞察SARS-CoV-2任何变体可能的生物学特性。由于奥密克戎与原始大流行毒株武汉-胡-1差异最大,我们预计奥密克戎病例会有不同的流行病学和临床模式。关于疫苗效力,一些表位的轻微变化而其他表位保持不变,不应导致已批准疫苗的效力显著降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/9017565/f235c71c8596/BRI2022-2164749.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/9017565/f235c71c8596/BRI2022-2164749.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c86c/9017565/f235c71c8596/BRI2022-2164749.001.jpg

相似文献

1
Annotating Spike Protein Polymorphic Amino Acids of Variants of SARS-CoV-2, Including Omicron.对包括奥密克戎在内的新型冠状病毒(SARS-CoV-2)变体的刺突蛋白多态性氨基酸进行注释。
Biochem Res Int. 2022 Apr 11;2022:2164749. doi: 10.1155/2022/2164749. eCollection 2022.
2
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.SARS-CoV-2 的奥密克戎和德尔塔变体:刺突蛋白的比较计算研究。
J Med Virol. 2022 Apr;94(4):1641-1649. doi: 10.1002/jmv.27526. Epub 2021 Dec 27.
3
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
4
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.严重急性呼吸综合征冠状病毒2型奥密克戎变异株的突变速度比追踪速度还快:刺突蛋白/血管紧张素转换酶2相互作用残基上的多个突变
Immune Netw. 2021 Dec 23;21(6):e38. doi: 10.4110/in.2021.21.e38. eCollection 2021 Dec.
5
A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.基于五螺旋的 SARS-CoV-2 融合抑制剂靶向针对 SARS-CoV-2 及其关注变体的七肽重复 2 结构域。
Viruses. 2022 Mar 13;14(3):597. doi: 10.3390/v14030597.
6
Adsorption of SARS CoV-2 spike proteins on various functionalized surfaces correlates with the high transmissibility of Delta and Omicron variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白在各种功能化表面上的吸附与德尔塔和奥密克戎变种的高传播性相关。
Mater Today Bio. 2022 Mar;14:100265. doi: 10.1016/j.mtbio.2022.100265. Epub 2022 Apr 19.
7
Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株蛋白的结构分析
Research (Wash D C). 2021 Dec 28;2021:9769586. doi: 10.34133/2021/9769586. eCollection 2021.
8
Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.新型关注变异株 SARS-CoV-2 奥密克戎(B.1.1.529)的特征及其全球视角。
J Med Virol. 2022 Apr;94(4):1738-1744. doi: 10.1002/jmv.27524. Epub 2022 Jan 11.
9
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.追踪 SARS-CoV-2 奥密克戎多样化的刺突基因突变,鉴定出多个变异株间重组事件。
Signal Transduct Target Ther. 2022 Apr 26;7(1):138. doi: 10.1038/s41392-022-00992-2.
10
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.天然和重组 SARS-CoV-2 分离株通过更有效地结合硫酸乙酰肝素和减少 S1/S2 裂解而迅速进化为更高的感染力。
J Virol. 2021 Oct 13;95(21):e0135721. doi: 10.1128/JVI.01357-21. Epub 2021 Aug 18.

引用本文的文献

1
Consensus insertion/deletions and amino acid variations of all coding and noncoding regions of the SARS-CoV-2 Omicron clades, including the XBB and BQ.1 lineages.奥密克戎各分支(包括 XBB 和 BQ.1 谱系)的所有编码和非编码区域的共识插入/缺失和氨基酸变异。
Arch Virol. 2023 May 8;168(6):156. doi: 10.1007/s00705-023-05787-6.
2
Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.表达 SARS-CoV-2 嵌合蛋白的重组卡介苗可保护 K18-hACE2 小鼠免受病毒攻击。
J Immunol. 2023 Jun 15;210(12):1925-1937. doi: 10.4049/jimmunol.2200731.

本文引用的文献

1
Clinical Features of Adult COVID-19 Patients without Risk Factors before and after the Nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant Outbreak in Korea: Experience from Gyeongsangnam-do.韩国全国范围内 SARS-CoV-2 B.1.617.2(德尔塔)变异株流行前后无危险因素的成年 COVID-19 患者的临床特征:来自庆尚南道的经验
J Korean Med Sci. 2021 Dec 20;36(49):e341. doi: 10.3346/jkms.2021.36.e341.
2
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.BNT162b2和mRNA-1273新冠疫苗在卡塔尔针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变种的有效性
Nat Med. 2021 Dec;27(12):2136-2143. doi: 10.1038/s41591-021-01583-4. Epub 2021 Nov 2.
3
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
巴西在与伽马变异株相关的新冠疫情中,科兴疫苗对老年人的有效性:一项基于病例对照研究的核酸阴性结果研究。
BMJ. 2021 Aug 20;374:n2015. doi: 10.1136/bmj.n2015.
4
The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus.与原始的 SARS-CoV-2 病毒相比,SARS-CoV-2 的 Delta 变体的繁殖数要高得多。
J Travel Med. 2021 Oct 11;28(7). doi: 10.1093/jtm/taab124.
5
O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule.新冠病毒刺突蛋白的O-糖基化模式揭示了“O随N”规则。
Cell Res. 2021 Oct;31(10):1123-1125. doi: 10.1038/s41422-021-00545-2. Epub 2021 Aug 2.
6
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.SARS-CoV-2 辅助蛋白在病毒发病机制中的作用:已知和未知。
Front Immunol. 2021 Jul 7;12:708264. doi: 10.3389/fimmu.2021.708264. eCollection 2021.
7
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.无论住院时新冠病情严重程度如何,新冠病毒2型特异性体液免疫和细胞免疫均可持续9个月。
Clin Transl Immunology. 2021 Jul 5;10(7):e1306. doi: 10.1002/cti2.1306. eCollection 2021.
8
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
9
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.冠状病毒科(Coronaviridae)的结构与功能
Science. 2021 Jun 18;372(6548):1306-1313. doi: 10.1126/science.abf3546. Epub 2021 May 13.
10
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.NVX-CoV2373 新冠疫苗对 B.1.351 变异株的有效性。
N Engl J Med. 2021 May 20;384(20):1899-1909. doi: 10.1056/NEJMoa2103055. Epub 2021 May 5.